Evidence map›Paper›PMID 27185376›Full record

ArticleMicrobiologyOpen2016

Effects of human serum and apo-Transferrin on Staphylococcus epidermidis RP62A biofilm formation.

Pengfei She, Lihua Chen, Yong Qi, Huan Xu, Yuan Liu, Yangxia Wang, Zhen Luo, Yong Wu

Open access · goldAbstract read
In one paragraph

Article in MicrobiologyOpen, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Omp34-MediatedAnalytical cellular pathology (Amsterdam) · 2025
    Article
  5. Host Soluble Factors Cause Changes inPathogens (Basel, Switzerland) · 2023
    Article
  6. Inhibitory effects of simeprevir onZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Determinants for persistence of Pseudomonas aeruginosa in hospitals: interplay between resistance, virulence and biofilm formation.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Pengfei SheDepartment of Medicine Clinical Laboratory, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Lihua ChenDepartment of Medicine Clinical Laboratory, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Yong QiDepartment of Medicine Clinical Laboratory, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Huan XuDepartment of Medicine Clinical Laboratory, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Yuan LiuDepartment of Medicine Clinical Laboratory, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Yangxia WangXiangya School of Medicine, Central South University, Changsha, 410013, China.
Zhen LuoDepartment of Medicine Clinical Laboratory, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Yong WuDepartment of Medicine Clinical Laboratory, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Central South University · CNThird Xiangya Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biofilm-associated Staphylococcus epidermidis infections present clinically important features due to their high levels of resistance to traditional antibiotics. As a part of human innate immune system, serum shows different degrees of protection against systemic S. epidermidis infection. We investigated the ability of human serum as well as serum component to inhibit the formation of, and eradication of mature S. epidermidis biofilms. In addition, the synergistic effect of vancomycin combined with apo-Transferrin was checked. Human serum exhibited significant antibiofilm activities against S. epidermidis at the concentration without affecting planktonic cell growth. However, there was no effect of human serum on established biofilms. By component separation, we observed that antibiofilm effect of serum components mainly due to the proteins could be damaged by heat inactivation (e.g., complement) or heat-stable proteins ≥100 kDa. In addition, serum apo-Transferrin showed modest antibiofilm effect, but without influence on S. epidermidis initial adhesion. And there was a synergistic antibiofilm interaction between vancomycin and apo-Transferrin against S. epidermidis. Our results indicate that serum or its components (heat-inactivated components or heat-stable proteins ≥100 kDa) could inhibits S. epidermidis biofilm formation. Besides, apo-Transferrin could partially reduce the biofilm formation at the concentration that does not inhibit planktonic cell growth.

Indexed as

Anti-Bacterial AgentsBacterial AdhesionBiofilmsDrug SynergismHumansImmune SeraMicrobial Sensitivity TestsStaphylococcal InfectionsStaphylococcus epidermidisTransferrinVancomycinAnti-Bacterial AgentsImmune SeraTransferrinVancomycinApo-Transferrinbiofilmcrystal violetserumStaphylococcus epidermidisXTT.

Identifiers

PMID27185376
PMCPMC5221445
OpenAlexW2398491076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.